COHANCE

HealthcareDrug Manufacturers - Specialty & GenericMid Cap
COHANCE LIFESCIENCES LTD

COHANCE LIFESCIENCES LTD (COHANCE) operates in the Healthcare sector, specifically as a Drug Manufacturer - Specialty & Generic. The company engages in contract research, developme...

हिन्दी में

COHANCE LIFESCIENCES LTD (COHANCE) हेल्थकेयर सेक्टर में, विशेष रूप से ड्रग मैन्युफैक्चरर्स - स्पेशलिटी एंड जेनेरिक के रूप में कार्यरत है। कंपनी न्यू केमिकल एंटिटी (NCE) आधारित इंटर...

₹441-0.32%1D
Previous trading day close · Data updates after market close
1W: -1.3%
1M: -0.5%
6M: +23.0%
1Y: -49.5%
47/100
Below AvgResearch Score
Market Cap
₹17.5K Cr
Mid Cap
P/E Ratio
97.01
Premium
P/B Ratio
9.45
Premium
ROE
13.8%
Decent
ROCE
9.2%
Average
Debt / Equity
0.15
Low debt
Div. Yield
N/A
EV/EBITDA
40.62
Expensive
52W Low: ₹266.7Current: ₹44152W High: ₹917.85
At 27% of 52-week range
Data as of previous trading day close · Updated after market close
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated after market close
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
54/100
Growth
Revenue, EPS, profit growth
41/100
Valuation
PE, PB, EV/EBITDA vs sector
24/100
Risk
Debt levels, volatility, coverage
73/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
97.01(Premium)
Forward P/E
68.21(Premium)
P/B Ratio
9.45(Premium)
P/S Ratio
7.55(Expensive)
EV/EBITDA
40.62(Expensive)
Dividend Yield
N/A
5Y CAGR
-1.5%(Moderate)
Revenue Growth
83.3%(High)
Profitability
ROE
13.8%(Average)
ROCE
9.2%(Average)
ROA
10.1%(Efficient)
Net Margin
7.8%(Low)
EBITDA Margin
18.7%
Financial Health
Debt to Equity
0.15(Low debt)
Current Ratio
2.43(Healthy)
Quick Ratio
1.98(Good)
Interest Coverage
6.56x(Comfortable)
Technical Indicators
Based on previous trading day close
RSI (14)
51(Neutral)
RSI Exp (14)
35(Neutral)
MACD
-0.098(Bearish)
MACD Signal
0.913
BB Position
33%(Middle)
BB Width
9.04%(Normal)
ADX (14)
19.2(Sideways)
Williams %R
-85.9(Oversold)
MFI (14)
71(Neutral)
CCI (20)
-66(Neutral)
Stoch %K
14(Oversold)
ATR (14)
18.09(Avg True Range)
OBV (M)
116.8(Positive)
1W OBV Chg
-2.1%(Decreasing)
Rel Volume
0.42x(Low activity)
Volatility
44.1%(High)
Max DD 1Y
-79.0%(High loss)
EMA 200
489.7
EMA 50
446.9
SMA 200
413.9
vs SMA 50
-1.5%(Below SMA50)
vs SMA 200
6.6%(Above SMA200)
Volume
4.60L
Avg Vol 3M
10.9L
Shareholding Pattern
Promoter
57.5%
High confidence
FII
5.6%
DII / MF
21.8%
Strong MF interest
Share COHANCE
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates after market close. Please consult a SEBI-registered advisor before investing.